Company Profile

Vigeo Therapeutics

Company Overview

Vigeo Therapeutics is a clinical-stage immuno-oncology company pioneering novel cancer therapies. Based in Cambridge, MA Vigeo is building a first-in-class drug development pipeline being led by VT1021, its dual-modulating compound that blocks the CD47 immune checkpoint and activates CD36.

Positions Available
Sort by:
  1. Position
  2. ▲ Date
  3. Location
Show All Details
This company currently has no jobs posted.

Click here to search for jobs.